• 1. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 2. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 3. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 4. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 5. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789

Comprehensive Guide to 1-(4-Fluorophenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride (CAS No. 1188264-17-6)

1-(4-Fluorophenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride (CAS 1188264-17-6) is a specialized heterocyclic compound with significant potential in pharmaceutical research and development. This compound belongs to the pyrazolo[4,3-c]pyridine family, which has garnered attention due to its structural versatility and bioactivity. Researchers and industry professionals frequently search for 1-(4-Fluorophenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride synthesis, applications in drug discovery, and its mechanism of action in biological systems.

The molecular structure of 1-(4-Fluorophenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride features a fluorophenyl group attached to a pyrazolo-pyridine core, which enhances its binding affinity to specific biological targets. This structural motif is often explored in the development of central nervous system (CNS) therapeutics and enzyme inhibitors. Recent trends in pharmaceutical chemistry highlight the growing interest in fluorinated heterocycles due to their improved metabolic stability and bioavailability.

One of the key applications of 1-(4-Fluorophenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride is in the field of neuropharmacology. Studies suggest that derivatives of this compound may interact with GABA receptors or serotonin transporters, making them candidates for treating anxiety and mood disorders. The inclusion of a fluorine atom in the phenyl ring is a strategic modification often employed to enhance lipophilicity and blood-brain barrier penetration.

From a synthetic chemistry perspective, the preparation of 1-(4-Fluorophenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride involves multi-step reactions, including cyclization and N-alkylation processes. Researchers frequently inquire about optimized synthetic routes and scalable production methods for this compound, as it serves as a valuable intermediate in medicinal chemistry programs.

The pharmacological profile of 1-(4-Fluorophenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride has also sparked interest in the context of personalized medicine. With the rise of computational drug design and AI-assisted molecular modeling, this compound is being studied for its potential to target specific genetic variants associated with neurological conditions. This aligns with the current focus on precision therapeutics in the pharmaceutical industry.

In terms of market dynamics, the demand for 1-(4-Fluorophenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride is driven by academic institutions and pharmaceutical companies engaged in CNS drug development. The compound's CAS number 1188264-17-6 is frequently referenced in patent literature and research publications, indicating its relevance in intellectual property related to neurological disorder treatments.

Quality control and analytical characterization of 1-(4-Fluorophenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride are critical for ensuring its suitability in research applications. Techniques such as HPLC, NMR spectroscopy, and mass spectrometry are commonly employed to verify the purity and structural integrity of this compound. Laboratories often search for certified reference standards and analytical protocols for this material.

Environmental and safety considerations for handling 1-(4-Fluorophenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride follow standard laboratory practices for research chemicals. While not classified as hazardous under normal research conditions, proper personal protective equipment (PPE) and ventilation systems are recommended when working with this compound in powder form.

The future research directions for 1-(4-Fluorophenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride may explore its potential in combination therapies or as a scaffold for developing novel psychotropic agents. The compound's structure-activity relationships continue to be an area of active investigation, particularly in the context of neurodegenerative disease research and cognitive enhancement studies.

For researchers seeking detailed information about 1-(4-Fluorophenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine hydrochloride (CAS 1188264-17-6), it is advisable to consult recent scientific literature and specialty chemical suppliers who can provide technical data sheets and custom synthesis services. The compound remains an important tool in advancing our understanding of neurochemical pathways and developing next-generation therapeutic agents.

• 396133-34-9(1-phenyl-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridine)
• 87629-24-1(3-(4-Fluorophenyl)-1-phenyl-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridine)
• 1075729-10-0(4,5,6,7-Tetrahydro-1-phenyl-1H-pyrazolo4,3-cpyridine Hydrochloride)
• 87629-59-2(1H-Pyrazolo[4,3-c]pyridine,3-(4-fluorophenyl)-4,5,6,7-tetrahydro-5-(1-methylethyl)-1-phenyl-,monohydrochloride)
• 87629-31-0(1,3-Bis(4-fluorophenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridine;hydrochloride)
• 833459-01-1(4,8-Methanopyrazolo[3,4-d]azepine,1-(4-fluorophenyl)-1,4,5,6,7,8-hexahydro-6-(phenylmethyl)-,monohydrochloride)
• 833458-99-4(4,8-Methanopyrazolo[3,4-d]azepine,1-(4-fluorophenyl)-1,4,5,6,7,8-hexahydro-6-(phenylmethyl)-)
• 851375-36-5(2H-Pyrazolo[4,3-c]pyridine, 4,5,6,7-tetrahydro-2,3-diphenyl-)
• 1171476-07-5(2-phenyl-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridine;dihydrochloride)
• 929973-74-0(2-phenyl-2H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine)